Drug Profile
Formoterol/glycopyrrolate - Cipla
Alternative Names: Formoterol/glycopyrronium - Cipla; Glycopyrrolate/formoterol - Cipla; Glycopyrronium/formoterol - CiplaLatest Information Update: 09 Apr 2021
Price :
$50
*
At a glance
- Originator Cipla
- Class Antiasthmatics; Antispasmodics; Antiulcers; Bronchodilators; Ethanolamines; Pyrrolidines; Quaternary ammonium compounds; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 09 Apr 2021 No development reported - Phase-III for Chronic obstructive pulmonary disease (In the elderly, In adults) in India (Inhalation)
- 28 Sep 2019 Adverse events and efficacy data from a phase III trial in Chronic obstructive pulmonary disease presented at the 29th Annual Congress of the European Respiratory Society (ESR-2019)
- 29 Jan 2019 Chemical structure information added